It has been determined that the levels of plasma angiogenin and angiopoietin after an incidence of ischemic stroke are low, and it has been attributed to poor outcomes, and interventions that may upregulate its expression can potentially improve stroke outcomes [26]. This evidence concerns the gene ANG and ischemic stroke.